| | 77-67-8 Basic information More.. |
| Product Name: | ETHOSUXIMIDE | | Synonyms: | Suxilep;Suximal;Suxin;Suxinutin;Thetamid;2-Methyl-2-ethylsuccinimide;3-Methyl-3-ethylsuccinimide;3-ethyl-3-methyl-5-pyrrolidinedione | | CAS: | 77-67-8 | | MF: | C7H11NO2 | | MW: | 141.17 | | EINECS: | 201-048-7 | | Mol File: | 77-67-8.mol |  |
Use
Hepatic impairment
Use with caution.
Renal impairment
Use with caution.
Pregnancy
The dose of ethosuximide should be monitored carefully during pregnancy and after delivery, and adjustments made on a clinical basis.
Ethosuximide crosses the placenta and cases of birth defects have been reported. Therefore, the prescribing physician should weigh the benefits versus the risks of ethosuximide in treating or counselling epileptic women of childbearing age.
Ethosuximide is excreted in breastmilk and the effects of ethosuximide on the nursing infant are unknown. Therefore, ethosuximide should be used in nursing mothers only if the benefits clearly outweigh the risks and breastfeeding is best avoided.
- Ethosuximide
-
- US $53.00 / mg
- 2024-11-19
- CAS:77-67-8
- Min. Order:
- Purity: 99.72%
- Supply Ability: 10g
- Ethosuximide
-
- US $53.00 / mg
- 2024-11-19
- CAS:77-67-8
- Min. Order:
- Purity: 99.72%
- Supply Ability: 10g
- Ethosuximide
-
- US $1.00 / KG
- 2020-01-10
- CAS:77-67-8
- Min. Order: 1KG
- Purity: ≥98%
- Supply Ability: 20 tons
|
|
77-67-8
Recommend Suppliers |
|